Pfizer and Astellas report positive data from prostate cancer therapy trial

Pfizer and Astellas report positive data from prostate cancer therapy trial

Source: 
Clinical Trials Arena
snippet: 

The trial evaluated enzalutamide, along with leuprolide, in non-metastatic, hormone-sensitive prostate cancer patients.